#ariba_ref_name	ref_name	gene	var_only	flag	reads	cluster	ref_len	ref_base_assembled	pc_ident	ctg	ctg_len	ctg_cov	known_var	var_type	var_seq_type	known_var_change	has_known_var	ref_ctg_change	ref_ctg_effect	ref_start	ref_end	ref_nt	ctg_start	ctg_end	ctg_nt	smtls_total_depth	smtls_nts	smtls_nts_depth	var_description	free_text
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	531	14010	16S	1529	1529	99.93	16S.l15.c17.ctg.1	2209	631.1	0	.	n	.	0	C1450T	SNP	1450	1450	C	1730	1730	T	755	T,C	702,3	.	.
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	531	14010	16S	1529	1529	99.93	16S.l15.c17.ctg.1	2209	631.1	1	SNP	n	C1184T	0	.	.	1184	1184	C	1464	1464	C	807	C,A	749,1	16S.rDNA_WHO_F_01361c:0:1:C1184T:16S.1184T:E coli C1192T. Resistance to Spectinomycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	26702	23S	2890	2890	99.9	23S.l15.c4.ctg.1	3508	758.0	0	.	n	.	0	T695C	SNP	695	695	T	1029	1029	C	768	C,T	710,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	26702	23S	2890	2890	99.9	23S.l15.c4.ctg.1	3508	758.0	0	.	n	.	0	G1337A	SNP	1337	1337	G	1671	1671	A	858	A	802	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	26702	23S	2890	2890	99.9	23S.l15.c4.ctg.1	3508	758.0	0	.	n	.	0	T1971C	SNP	1971	1971	T	2305	2305	C	858	C,T	792,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	26702	23S	2890	2890	99.9	23S.l15.c4.ctg.1	3508	758.0	1	SNP	n	A2045G	0	.	.	2045	2045	A	2379	2379	A	827	A	785	23S.rDNA_WHO_F_01358c:0:1:A2045G:23S.2045G:E coli A2059G. High-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	26702	23S	2890	2890	99.9	23S.l15.c4.ctg.1	3508	758.0	1	SNP	n	C2597T	0	.	.	2597	2597	C	2931	2931	C	817	C	778	23S.rDNA_WHO_F_01358c:0:1:C2597T:23S.2597T :E coli C2611T. Low-level resistance to Azithromycin	.
folP.WHO_V_01427c	folP.WHO_V_01427c	1	1	27	2010	folP	855	855	100.0	folP.l15.c4.ctg.1	1496	133.7	1	SNP	p	R229S	1	.	.	685	687	AGC	977	979	AGC	221;219;219	A;G;C	215;214;213	folP.WHO_V_01427c:1:1:R229S:folP.228S:Resistance to sulphonamides	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	5174	gyrA	2751	2751	99.85	gyrA.l15.c30.ctg.1	3321	155.1	1	SNP	p	S91F	1	.	.	271	273	TTC	601	603	TTC	186;186;185	T;T;C	172;175;174	gyrA.WHO_M_01098:1:1:S91F:gyrA.91F:Resistance to fluoroquinolones	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	5174	gyrA	2751	2751	99.85	gyrA.l15.c30.ctg.1	3321	155.1	1	SNP	p	D95G	1	.	.	283	285	GGC	613	615	GGC	188;188;186	G;G;C	177;174;171	gyrA.WHO_M_01098:1:1:D95G:gyrA.95G:Resistance to fluoroquinolones	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	5174	gyrA	2751	2751	99.85	gyrA.l15.c30.ctg.1	3321	155.1	1	SNP	p	G95N	0	.	.	283	285	GGC	613	615	GGC	188;188;186	G;G;C	177;174;171	gyrA.WHO_M_01098:1:1:G95N:gyrA.95N:Resistance to fluoroquinolones	.
mtrR.WHO_V_01454	mtrR.WHO_V_01454	1	1	27	1548	mtrR	633	633	100.0	mtrR.l15.c30.ctg.1	1196	128.2	1	SNP	p	G45D	0	.	.	133	135	GGC	423	425	GGC	210;209;210	G;G;C	197;197;196	mtrR.WHO_V_01454:1:1:G45D:mtrR.45D:Increased efflux of antimicrobials, e.g. macrolides and b-lactam antimicrobials, that are substrates of the MtrCDE efflux pump	.
mtrR_promoter.WHO_F	mtrR_promoter.WHO_F	0	0	531	864	mtrR_promoter	250	250	99.6	mtrR_promoter.l15.c30.ctg.1	998	85.8	0	.	n	.	0	A197.	DEL	197	197	A	566	566	A	217	A	199	.	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	4926	parC	2304	2304	100.0	parC.l6.c4.ctg.1	2889	169.7	1	SNP	p	D86N	0	.	.	256	258	GAC	559	561	GAC	220;222;221	G;A;C	201;201;205	parC.WHO_Y_00247c:1:1:D86N:parC.86N:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	4926	parC	2304	2304	100.0	parC.l6.c4.ctg.1	2889	169.7	1	SNP	p	R87I	0	.	.	259	261	CGT	562	564	CGT	219;217;221	C;G;T	202;202;204	parC.WHO_Y_00247c:1:1:R87I:parC.87I:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	4926	parC	2304	2304	100.0	parC.l6.c4.ctg.1	2889	169.7	1	SNP	p	S87R	1	.	.	259	261	CGT	562	564	CGT	219;217;221	C;G;T	202;202;204	parC.WHO_Y_00247c:1:1:S87R:parC.87R:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	4926	parC	2304	2304	100.0	parC.l6.c4.ctg.1	2889	169.7	1	SNP	p	R87W	0	.	.	259	261	CGT	562	564	CGT	219;217;221	C;G;T	202;202;204	parC.WHO_Y_00247c:1:1:R87W:parC.87W:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	4926	parC	2304	2304	100.0	parC.l6.c4.ctg.1	2889	169.7	1	SNP	p	S88P	0	.	.	262	264	TCC	565	567	TCC	223;220;222	T;C;C	205;203;202	parC.WHO_Y_00247c:1:1:S88P:parC.88P:Resistance to fluoroquinolones	.
parE.WHO_F_01528c	parE.WHO_F_01528c	1	1	27	4290	parE	1986	1986	100.0	parE.l15.c4.ctg.1	2668	159.8	1	SNP	p	G410V	0	.	.	1228	1230	GGC	1471	1473	GGC	194;193;191	G;G;C	180;180;179	parE.WHO_F_01528c:1:1:G410V:parE.410V:Resistance to fluoroquinolones	.
penA.5.002	penA.5.002	1	1	27	3970	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2419	163.4	1	SNP	p	A311V	0	.	.	931	933	GCA	1252	1254	GCA	222;220;216	G;C;A	202;200;198	penA.5.002:1:1:A311V:penA.311V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	3970	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2419	163.4	1	SNP	p	I312M	0	.	.	934	936	ATC	1255	1257	ATC	221;224;223	A;T;C	203;206;203	penA.5.002:1:1:I312M:penA.312M:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	3970	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2419	163.4	1	SNP	p	V316P	0	.	.	946	948	GTG	1267	1269	GTG	212;212;209	G;T;G	198;195;195	penA.5.002:1:1:V316P:penA.316P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	3970	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2419	163.4	1	SNP	p	V316T	0	.	.	946	948	GTG	1267	1269	GTG	212;212;209	G;T;G	198;195;195	penA.5.002:1:1:V316T:penA.316T:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	3970	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2419	163.4	1	SNP	p	T484S	0	.	.	1450	1452	ACC	1771	1773	ACC	218;219;217	A;C;C	196;204;199	penA.5.002:1:1:T484S:penA.483S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	3970	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2419	163.4	1	SNP	p	A502P	0	.	.	1504	1506	GCG	1825	1827	GCG	211;210;213	G;C;G	192;177;182	penA.5.002:1:1:A502P:penA.501P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	3970	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2419	163.4	1	SNP	p	A502V	0	.	.	1504	1506	GCG	1825	1827	GCG	211;210;213	G;C;G	192;177;182	penA.5.002:1:1:A502V:penA.501V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	3970	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2419	163.4	1	SNP	p	G543S	1	.	.	1627	1629	AGC	1948	1950	AGC	164;163;161	A;G;C	156;151;153	penA.5.002:1:1:G543S:penA.542S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	3970	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2419	163.4	1	SNP	p	G546S	0	.	.	1636	1638	GGC	1957	1959	GGC	151;151;149	G;G;C	143;139;139	penA.5.002:1:1:G546S:penA.545S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	3970	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2419	163.4	1	SNP	p	P552S	0	.	.	1654	1656	CCG	1975	1977	CCG	137;139;141	C,G;C;G,A	94,6;93;97,1	penA.5.002:1:1:P552S:penA.551S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
ponA.WHO_G_00106	ponA.WHO_G_00106	1	1	539	5522	ponA	2397	2397	99.96	ponA.l15.c4.ctg.1	3238	169.9	0	.	p	.	0	A375T	NONSYN	1123	1125	GCG	1673	1675	ACG	226;226;226	A;C;G	209;208;209	.	.
ponA.WHO_G_00106	ponA.WHO_G_00106	1	1	539	5522	ponA	2397	2397	99.96	ponA.l15.c4.ctg.1	3238	169.9	1	SNP	p	L421P	1	.	.	1261	1263	CCG	1811	1813	CCG	180;180;180	C;C;G	160;168;166	ponA.WHO_G_00106:1:1:L421P:ponA.421P:High-level chromosomally-mediated penicillin resistance	.
porA.NCCP11945	porA.NCCP11945	1	0	531	2204	porA	1146	1146	99.91	porA.l15.c17.ctg.1	1619	134.4	0	.	p	.	0	M83fs	FSHIFT	247	247	A	473	473	C	142	C	133	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	2608	porB1b	1047	1047	99.04	porB1b.l6.c4.ctg.1	1550	166.8	0	.	p	.	0	N38E	NONSYN	112	114	AAT	368	370	GAA	257;255;253	G;A;A	242;241;239	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	2608	porB1b	1047	1047	99.04	porB1b.l6.c4.ctg.1	1550	166.8	0	.	p	.	0	N134D	NONSYN	400	402	AAT	656	658	GAT	205;208;210	G;A;T	189;189;190	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	2608	porB1b	1047	1047	99.04	porB1b.l6.c4.ctg.1	1550	166.8	0	.	p	.	0	P175S	NONSYN	523	525	CCA	779	781	TCA	212;216;217	T;C;A	199;201;205	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	2608	porB1b	1047	1047	99.04	porB1b.l6.c4.ctg.1	1550	166.8	0	.	p	.	0	E204G	NONSYN	610	612	GAA	866	868	GGA	187;188;187	G;G;A	177;177;170	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	2608	porB1b	1047	1047	99.04	porB1b.l6.c4.ctg.1	1550	166.8	0	.	p	.	0	D212N	NONSYN	634	636	GAT	890	892	AAT	192;190;190	A;A;T	189;185;183	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	2608	porB1b	1047	1047	99.04	porB1b.l6.c4.ctg.1	1550	166.8	0	.	p	.	0	A218V	NONSYN	652	654	GCC	908	910	GTC	182;180;180	G;T;C	175;176;178	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	2608	porB1b	1047	1047	99.04	porB1b.l6.c4.ctg.1	1550	166.8	0	.	p	.	0	F222S	NONSYN	664	666	TTT	920	922	TCT	188;189;189	T;C,T;T	184;183,1;184	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	2608	porB1b	1047	1047	99.04	porB1b.l6.c4.ctg.1	1550	166.8	0	.	p	.	0	E328A	NONSYN	982	984	GAA	1238	1240	GCA	176;172;171	G;C;A	165;164;164	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	2608	porB1b	1047	1047	99.04	porB1b.l6.c4.ctg.1	1550	166.8	1	SNP	p	G120K	1	.	.	358	360	AAG	614	616	AAG	201;205;205	A;A;G	188;191;190	porB1b.WHO_V_02265c:1:1:G120K:porB1b.120K:G101K. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	2608	porB1b	1047	1047	99.04	porB1b.l6.c4.ctg.1	1550	166.8	1	SNP	p	D121N	0	.	.	361	363	GAC	617	619	GAC	202;199;201	G;A;C	186;185;187	porB1b.WHO_V_02265c:1:1:D121N:porB1b.121N:A102N. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	2608	porB1b	1047	1047	99.04	porB1b.l6.c4.ctg.1	1550	166.8	1	SNP	p	A121D	1	.	.	361	363	GAC	617	619	GAC	202;199;201	G;A;C	186;185;187	porB1b.WHO_V_02265c:1:1:A121D:porB1b.121D:A102D. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
rpoB.WHO_M_02157	rpoB.WHO_M_02157	1	1	27	9808	rpoB	4179	4179	99.98	rpoB.l15.c17.ctg.1	4806	203.4	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.
rpsJ.WHO_Y_02241	rpsJ.WHO_Y_02241	1	1	27	1176	rpsJ	312	312	100.0	rpsJ.l15.c4.ctg.1	1017	114.6	1	SNP	p	V57M	1	.	.	169	171	ATG	521	523	ATG	265;264;265	A;T;G	252;248;248	rpsJ.WHO_Y_02241:1:1:V57M:rpsJ.57M:Chromosomally-mediated resistance to tetracyclines	.
